Clinical trial NCT06408675: Loss of Cervical Lordosis in Fibromyalgia Syndrome
Official title: Loss of Cervical Lordosis an Association of Fibromyalgia Syndrome
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Fibromyalgia, Cervical Lordosis
Keywords: Fibromyalgia, cervical lordosis
Lead sponsor: Ankara City Hospital Bilkent
Sponsor class: OTHER
First posted: 2024-05-10
Enrollment: 107
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Observational model: OTHER
Time perspective: CROSS_SECTIONAL
Sampling method: PROBABILITY_SAMPLE
Study population: A total of 107 patients who applied to the physical therapy and rehabilitation outpatient clinic; . Age range between 18-65 , male-female, Patients diagnosed with fibromyalgia according to the American College of Rheumatology 1990 criteria

Brief summary: Purpose: The causes of chronic and widespread pain in fibromyalgia (FMS) have not been eluciated yet. Previous reports determined that posture control changed, muscle strength decreased, body posture misaligned (maladaptive posture), and functional capacity decreased in FMS patients. The aim of this study was to investigate the relationship between loss of cervical lordosis, pain, quality of life (QOL) and neck disability in patients with FMS.

Methods: A total of 107 FMS (88 females and 20 males; range of age:18-65) were included to the study. Patients were divided into two groups according to the angle of cervical lordosis measured by the Cobb method, group 1 with a Cobb angle of ≤10°, and group 2 with an angle greater than \>10°. Visual Analog Scale (VAS), QOL (36-Item Short Form Survey (SF-36)), and Neck Disability Index (NDI) were used to assess pain, overall quality of life, functional disability respectively.


Eligibility criteria: Inclusion Criteria:

Age range between 18 and 65

-Patients diagnosed with fibromyalgia according to the American College of Rheumatology 1990 criteria

Exclusion Criteria:

Patients diagnosed with known systemic (e.g., inflammatory rheumatic diseases, diabetes mellitus and systemic arterial hypertension), metabolic or endocrine diseasesas well as tumoral, neurologic or infectious diseases,

* Patients with a history of trauma and surgery affecting the neck area,
* Patients who received trigger point injection therapy for neck pain within the last 6 months,
* Patients with cervical disc herniation or myelopathy, spondylolisthesis, spondylolysis, cervicothoracic kyphoscoliosis,
* Patients who had been receiving therapy for any psychiatric diagnosis for the last 3 months and antidepressant drug use,
* Patients with history of neuropathic diseases,
* Patients with a condition affecting neck muscles, such as dystonia,
* Inflammatory muscle disease and myopathy
* Pregnant patients were not included to the study

Primary outcomes:
measure: Visual analogue scale (VAS)
timeFrame: day 1,
Secondary outcomes:
measure: Quality of Life Scale-Short Form (SF-36)
timeFrame: day 1.
measure: Neck disability index (NDI)
timeFrame: day 1
Other outcomes:
Locations:
city: Ankara
country: Turkey
facility: Ankara City Hospital
state: Çankaya
city: Ankara
country: Turkey
facility: Emine Esra Bilir
state: Çankaya
Study officials:
References: